clinical trial · NCT03015532
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
Postoperative PainHTX-011Saline PlaceboBupivicaine HClRopivacaine
brief summary
This is a Phase 2b, randomized, double-blind, saline placebo- and active-controlled, multicenter study in subjects undergoing primary unilateral total knee arthroplasty (TKA) to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of HTX-011 administered via infiltration to the surgical site.
started
Jan 13, 2017
primary completion
Apr 20, 2018
completion
May 16, 2018
last updated
Mar 2, 2026
official title
A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol